Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-dependent enzyme topoisomerase II (Topo II) is a large, ATP-dependent homodimeric enzyme found in all eukaryotes and many prokaryotes. It plays a critical role in managing the topological states of DNA during essential cellular processes such as replication, transcription, recombination, and chromosome segregation. It alters DNA topology by introducing transient double-stranded breaks in the DNA helix to resolve supercoiling, knots, and tangles. Topo II is a major target for anticancer drugs.
Stabilizes covalent enzyme-DNA intermediates, leading to double-strand breaks; catalytic inhibition.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-dependent enzyme topoisomerase II (TopoII).